Home » Pharma News (page 15)

Pharma News

Rs 2,277 drug can treat hepatitis B patients

Rs 2,277 drug can treat hepatitis B patients An effective drug for treating hepatitis B virus (HBV) could be mass-produced for as little as USD 36 per person per year against the current US price of over USD 15,000, scientists say. The advance could lead to huge reductions in the number of people being infected with Hepatitis B which causes ... Read More »

Sun Pharma plunges 11% as Daiichi Sankyo sells 8.9% stake

Sun Pharma plunges 11% as Daiichi Sankyo sells 8.9% stake Shares of  Sun Pharma  plunged 11 percent intraday on Tuesday after Daiichi Sankyo decided to offload its stake. Daiichi Sankyo has sold its its entire 8.9 percent stake via multiple blocks at between Rs 930-968 per share (lower end of the band). Daiichi has raised USD 3 billion via stake sale in Sun Pharma. Daiichi ... Read More »

Bar-coding of drugs becomes mandatory to trace their origins

Bar-coding of drugs becomes mandatory to trace their origins    The government has mandated bar-coding of mono cartons of drugs shipped out of the country from July as an additional measure to ensure that its reputation isn’t tarnished by medicines manufactured illicitly in other countries and passed off as made in India. Bar-coding of mono cartons, which hold primary packs ... Read More »

UTMB researchers develop Ebola vaccine effective in a single dose

UTMB researchers develop Ebola vaccine effective in a single dose An interdisciplinary team from The University of Texas Medical Branch at Galveston and Profectus BioSciences, Inc. has developed a quick-acting vaccine that is both safe and effective with a single dose against the Ebola strain that killed thousands of people in West Africa last year. These findings are detailed in ... Read More »

12 of top 25 pharma shares rally over 100% in FY15

12 of top 25 pharma shares rally over 100% in FY15 Fiscal 2014-15 (FY15) has turned out to be a good year for pharmaceutical companies with nearly half of the top 25 pharma stocks becoming multi-baggers during the year. As many as 12 out of top 25 most valued pharmaceutical firms have seen price appreciation of more than 100% during ... Read More »

Novartis accelerates cancer immunotherapy efforts with Aduro Biotech alliance and launch of new immuno-oncology research group

Novartis accelerates cancer immunotherapy efforts with Aduro Biotech alliance and launch of new immuno-oncology research group Novartis announced today that it is stepping up its efforts to harness the body’s immune system to combat cancer. The company has entered into a major multiyear alliance with Aduro Biotech that is focused on the discovery and development of next generation cancer immunotherapies ... Read More »

US FDA approves Semler Scientific’s next generation PAD testing system

US FDA approves Semler Scientific’s next generation PAD testing system The US Food and Drug Administration (FDA) has granted 510(k) marketing clearance for Semler Scientific’s next generation peripheral artery disease (PAD) testing system. The next generation system features convenience and ease of use characteristics along with compatibility to electronic medical record systems for easy accessibility of data. The system was ... Read More »

GSK becomes partner in new global fund to accelerate dementia research

GSK becomes partner in new global fund to accelerate dementia research GSK today announced it will be a key partner, with an investment of $25m (approx £17m), in a pioneering new global fund for dementia research. The Dementia Discovery Fund, which is being established by the UK government with initial commitments totalling $100m, brings together leading pharmaceutical companies, the UK ... Read More »

Drug major LupinBSE -0.77 % has inked a pact to acquire an additional 40 per cent stake in South Africa’s Pharma Dynamics

Drug major LupinBSE -0.77 % has inked a pact to acquire an additional 40 per cent stake in South Africa’s Pharma Dynamics NEW DELHI: Drug major LupinBSE -0.77 % has inked a pact to acquire an additional 40 per cent stake in South Africa’s Pharma Dynamics, taking its holding in the company to 100 per cent. Lupin had earlier acquired ... Read More »

BIGTheme.net • Free Website Templates - Downlaod Full Themes